PhenoCycler-Fusion (CODEX)® technology target subsets of an antibody panel via repetitive imaging cycles, revealing 40+ biomarkers in a tissue section.
PhenoCycler-Fusion (CODEX)® Technology and Workflow Steps
Secondary Antibodies
Leinco Technologies offers a wide range of second step reagents including secondary antibodies, streptavidin and UltraAvidin™.
In vivo GOLD™ vs. In vivo PLATINUM™ Antibodies
Leinco Technologies provides in vivo functional grade antibodies with the highest purity standards in the industry: In vivo GOLDTM & In vivo PLATINUMTM.
Why should you use Isotype Control Antibodies – MBL
Isotype control antibodies optimise study performance & data analysis in therapeutic antibody research, which is key to drug development.
My Cites are Set on You!
ProSci-Inc’s RIP3/RIPK3 antibody (Cat. No. PSI-2283) is widely cited with as many as 171 citations on CiteAb and 165 citations on Bioz.
Deliver Functional Proteins and Antibodies into Living Cells
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
The Impact of In Vivo Isotype Controls on Therapeutic Drug Development – MBL
The significance of antibody-based in vivo studies For both research and therapeutic purposes, antibodies can be used to affect cellular processes in vivo and are referred to as functional/in vivo grade antibodies. There is a wide range of applications for
The Role of Monoclonal Antibodies & Biosimilars in Life Science Research
mAbs (biosimilars) as tools to research novel new therapies and uncover effective off-target application.
Monoclonal Antibody Drugs for Cancer
Monoclonal antibody drugs have emerged as powerful tools in the fight against cancer, revolutionising treatment approaches.
Insights into the Molecular Mechanisms Regulating Necroptosis
This white paper details findings in molecular mechanisms that govern necroptosis related to RIPK & details #2283 use to analyse expression of RIPK3.